Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Lupi: Lipotoxicity in human pancreatic islets and the protective effect of metformin. (0.09 sec) 

Lipotoxicity in human pancreatic islets and the protective effect of metformin

- diabetesjournals.org
R Lupi, S Del Guerra, V Fierabracci, L Marselli … - Diabetes, 2002 - Am Diabetes Assoc
Human pancreatic islets from eight donors were incubated for 48 h in the
presence of 2.0 mmol/l free fatty acid (FFA) (oleate to palmitate, 2 to 1).
Insulin secretion was then assessed in response to glucose (16.7 mmol/l), ...
Cited by 80 - Related articles - BL Direct - All 5 versions

On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors

- diabetesjournals.org [PDF] 
SA Hinke, CHS McIntosh, T Hoffmann, K … - Diabetes Care, 2002 - Am Diabetes Assoc
The provision of diabetes care has shifted from the specialist to the generalist
in primary care practice. Evidence suggests utilization of nonphy- sician
providers in conjunction with phy- sician-directed protocols improves ...
Cited by 28 - Related articles - BL Direct - All 5 versions

[CITATION] Single dose treatment of diabetic patients by the DPIV inhibitor P32/98


HU Demuth, T Hoffmann, K Glund, CHS … - EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY …, 2000 - Johann Ambrosius Barth; 1999
Cited by 33 - Related articles - BL Direct

Effect of glucagon-like peptide 1 on non–insulin-mediated glucose uptake in the elderly …

- Free from Publisher
GS Meneilly, CHS McIntosh, RA Pederson, JF … - Diabetes Care, 2001 - Am Diabetes Assoc
An important cause of elevated glucose levels in elderly patients with diabetes
is an alteration in non–insulin-mediated glucose uptake (NIMGU). Glucagon-like
peptide 1 (GLP-1) is an intestinal insulinotropic hormone. It has been ...
Cited by 61 - Related articles - BL Direct - All 5 versions

Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese …

- diabetesjournals.org
E Mannucci, A Ognibene, F Cremasco, G … - Diabetes Care, 2001 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 10 obese nondiabetic male patients were
studied before and after a 14-day treatment with 2,550 mg/day metformin and were
compared with 10 untreated obese control subjects. On days 0 and 15, leptin ...
Cited by 105 - Related articles - BL Direct - All 9 versions

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: …

- physiology.org
R Lupi, S Del Guerra, L Marselli, M Bugliani, … - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc
Peroxisome proliferator-activated receptors (PPARs) are a subgroup of the
superfamily of nuclear receptors, with three distinct main types: , and
(subdivided into 1 and 2 ). Recently, the presence of PPAR has been ...
Cited by 78 - Related articles - BL Direct - All 4 versions

Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high …

- diabetesjournals.org [PDF] 
G Patane, S Piro, AM Rabuazzo, M Anello, R … - Diabetes, 2000 - Am Diabetes Assoc
Because metformin affects glucose and free fatty acid (FFA) metabolism in
peripheral insulin target tissues, we investigated the effect of this drug in
restoring a nor- mal secretory pattern in rat pancreatic islets whose ...
Cited by 88 - Related articles - BL Direct - All 5 versions

The biguanide compound metformin prevents desensitization of human pancreatic islets …


R Lupi, S Del Guerra, C Tellini, R Giannarelli, … - European journal of pharmacology, 1999 - Elsevier
Pancreatic islet desensitization by high glucose concentrations is a temporary
and reversible state of beta-cell refractoriness to glucose (and possibly other
secretagogues), due to repeated or prolonged pre-exposure to increased ...
Cited by 28 - Related articles - All 5 versions

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release …

- nih.gov [PDF] 
DA D'alessio, SE Kahn, CR Leusner, JW … - Journal of Clinical Investigation, 1994 - pubmedcentral.nih.gov
Glucagon-like peptide1 [7-36 amidel (GLP-1) has been shown to enhance insulin
secretion in healthy and type II diabetic hu- mans, and to increase glucose
disposal in type I diabetic pa- tients. To further define its action on ...
Cited by 172 - Related articles - BL Direct - All 6 versions

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human …


R Lupi, F Dotta, L Marselli, S Del Guerra, M … - Diabetes, 2002 - Am Diabetes Assoc
In an effort to better understand the phenomenon of lipotoxicity in human
β-cells, we evaluated the effects of 48-h preculture with 1.0 or 2.0 mmol/l
free fatty acid (FFA) (2:1 oleate to palmitate) on the function and ...
Cited by 268 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google